↓ Skip to main content

Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, January 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#4 of 411)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
25 news outlets
blogs
2 blogs
twitter
27 tweeters
video
1 video uploader

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
35 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997
Published in
Journal of Pharmaceutical Policy and Practice, January 2021
DOI 10.1186/s40545-020-00282-8
Pubmed ID
Authors

Babak Sahragardjoonegani, Reed F. Beall, Aaron S. Kesselheim, Aidan Hollis

Twitter Demographics

The data shown below were collected from the profiles of 27 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 35 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 20%
Unspecified 6 17%
Student > Master 3 9%
Student > Ph. D. Student 2 6%
Other 1 3%
Other 5 14%
Unknown 11 31%
Readers by discipline Count As %
Unspecified 6 17%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Biochemistry, Genetics and Molecular Biology 3 9%
Agricultural and Biological Sciences 2 6%
Immunology and Microbiology 2 6%
Other 7 20%
Unknown 12 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 227. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2022.
All research outputs
#140,032
of 22,971,207 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#4
of 411 outputs
Outputs of similar age
#4,304
of 500,606 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#1
of 20 outputs
Altmetric has tracked 22,971,207 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 411 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 500,606 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.